Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
IRF3 reduces adipose thermogenesis via ISG15-mediated reprogramming of glycolysis
Shuai Yan, … , Rasheed Ahmad, Evan D. Rosen
Shuai Yan, … , Rasheed Ahmad, Evan D. Rosen
Published February 11, 2021
Citation Information: J Clin Invest. 2021;131(7):e144888. https://doi.org/10.1172/JCI144888.
View: Text | PDF
Research Article Metabolism

IRF3 reduces adipose thermogenesis via ISG15-mediated reprogramming of glycolysis

  • Text
  • PDF
Abstract

Adipose thermogenesis is repressed in obesity, reducing the homeostatic capacity to compensate for chronic overnutrition. Inflammation inhibits adipose thermogenesis, but little is known about how this occurs. Here we showed that the innate immune transcription factor IRF3 is a strong repressor of thermogenic gene expression and oxygen consumption in adipocytes. IRF3 achieved this by driving expression of the ubiquitin-like modifier ISG15, which became covalently attached to glycolytic enzymes, thus reducing their function and decreasing lactate production. Lactate repletion was able to restore thermogenic gene expression, even when the IRF3/ISG15 axis was activated. Mice lacking ISG15 phenocopied mice lacking IRF3 in adipocytes, as both had elevated energy expenditure and were resistant to diet-induced obesity. These studies provide a deep mechanistic understanding of how the chronic inflammatory milieu of adipose tissue in obesity prevents thermogenic compensation for overnutrition.

Authors

Shuai Yan, Manju Kumari, Haopeng Xiao, Christopher Jacobs, Shihab Kochumon, Mark Jedrychowski, Edward Chouchani, Rasheed Ahmad, Evan D. Rosen

×

Figure 6

Glycolytic enzymes are key ISG15 substrates in beige adipocytes.

Options: View larger image (or click on image) Download as PowerPoint
Glycolytic enzymes are key ISG15 substrates in beige adipocytes.
(A) Gen...
(A) Gene Ontology analysis (biological process) of ISGylated proteins (n = 3). (B) Volcano plot of proteomic analysis. Red dots represent glycolytic enzymes. Black lines indicate significantly enriched or de-enriched proteins (FDR = 0.05) (n = 3). (C) Heatmap of glycolytic protein levels from mass spectrometric analysis (n = 3). (D) Western blot of glycolytic enzymes in beige adipocytes expressing GFP or FLAG-ISG15 pulled down by IgG or anti-FLAG antibody. (E) Extracellular acidification rate (ECAR) of WT and Isg15–/– beige adipocytes (n = 8). 2-DG, 2-dexoy-d-glucose. (F) ECAR in Isg15–/– beige adipocytes expressing GFP or mouse ISG15 (n = 8). mpH, milli pH units. (G) Basal ECAR in WT and Irf3–/– beige adipocytes expressing GFP or mouse ISG15 (n = 8). (H) Basal ECAR in WT and FI3OE beige adipocytes expressing GFP or mouse ISG15 (n = 8). Statistical comparisons were made using 2-way ANOVA (E and F) or 2-tailed Student’s t test (G and H). Data are presented as mean ± SEM. *P < 0.05; #P < 0.05 vs. WT.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts